UC Davis Clinical Trial Shows Biomarkers May Hold Clue in Treating Aggressive Prostate Cancer

UC Davis Clinical Trial Shows Biomarkers May Hold Clue in Treating Aggressive Prostate Cancer

Gene mutations are likely to play a key role in treating aggressive prostate cancer, according to a new UC Davis clinical trial creating hope for men.

Isotopia And Cardirad Announce Launch Of Isoprotrace ® In Sweden And Denmark, Expanding Access To Advanced Prostate Cancer Imaging - Medical Device News Magazine

The introduction of Isoprotrace® into these Nordic markets marks a significant step forward in expanding access to precision diagnostic tools for prostate cancer.

New Prostate Cancer Test Uses Machine Learning to Efficiently Spot New Cancer Biomarkers Accurately and Non-Invasively

Researchers in Sweden develop urine test that more effectively screens for prostate cancer than standard PSA test Clinical laboratories may soon have a new inexpensive, non-invasive urine test to screen for prostate cancer that produces superior results compared to the standard PSA test. An international team of scientists led by researchers at the Karolinska Institutet […] The post New Prostate Cancer Test Uses Machine Learning to Efficiently S…